• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柠檬酸盐:如何开始以及监测什么、何时监测和如何监测?

Citrate: How to Get Started and What, When, and How to Monitor?

作者信息

Honore Patrick M, De Bels David, Preseau Thierry, Redant Sebastien, Spapen Herbert D

机构信息

ICU Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

Emergency Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

出版信息

J Transl Int Med. 2018 Oct 9;6(3):115-127. doi: 10.2478/jtim-2018-0026. eCollection 2018 Sep.

DOI:10.2478/jtim-2018-0026
PMID:30425947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6231307/
Abstract

In most of the case, regional citrate anticoagulation is using diluted citrate around 1% depending on the types used in clinical practice. Diluted citrate is much more safer when compared to highly concentrated citrate around 4% or even more. In clinical practice, trisodium citrate is used in high concentration (around 30%) as a bactericidal agent with anticoagulant properties for locking deep venous catheters used in hemodialysis (HD; close to 25-30% of citrate). In this review article, buffer and anticoagulant potential of citrate are discussed during renal replacement therapy in critically ill patients with particular focus on the practical approach at the bedside.

摘要

在大多数情况下,根据临床实践中使用的类型,局部枸橼酸抗凝使用的是浓度约为1%的稀释枸橼酸盐。与浓度约为4%甚至更高的高浓度枸橼酸盐相比,稀释枸橼酸盐要安全得多。在临床实践中,枸橼酸钠以高浓度(约30%)用作具有抗凝特性的杀菌剂,用于锁定血液透析(HD)中使用的深静脉导管(接近25%-30%的枸橼酸盐)。在这篇综述文章中,讨论了枸橼酸盐在危重症患者肾脏替代治疗期间的缓冲和抗凝潜力,特别关注床边的实际应用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/6231307/dacf626e010f/jtim-06-115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/6231307/dacf626e010f/jtim-06-115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/6231307/dacf626e010f/jtim-06-115-g001.jpg

相似文献

1
Citrate: How to Get Started and What, When, and How to Monitor?柠檬酸盐:如何开始以及监测什么、何时监测和如何监测?
J Transl Int Med. 2018 Oct 9;6(3):115-127. doi: 10.2478/jtim-2018-0026. eCollection 2018 Sep.
2
Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.肝素与枸橼酸盐作为急性肾衰竭需要肾脏替代治疗患者非隧道式中心静脉血液透析导管封管溶液的比较(VERROU-REA研究):一项随机对照试验的研究方案
Trials. 2014 Nov 19;15:449. doi: 10.1186/1745-6215-15-449.
3
Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.危重症患者连续性持续低效透析(C-SLED)中局部枸橼酸盐抗凝的安全性
Ren Fail. 2005;27(5):541-5. doi: 10.1080/08860220500198748.
4
Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.局部枸橼酸抗凝用于高出血风险外科患者的大容量连续性静脉-静脉血液透析
Ther Apher Dial. 2013 Apr;17(2):202-12. doi: 10.1111/j.1744-9987.2012.01101.x. Epub 2012 Aug 29.
5
Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.小儿重症监护中持续肾脏替代治疗期间的枸橼酸盐抗凝
Pediatr Crit Care Med. 2014 Jun;15(5):471-85. doi: 10.1097/PCC.0000000000000148.
6
Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation.接受局部枸橼酸盐抗凝持续肾脏替代治疗的危重症患者的高乳酸血症、乳酸动力学及枸橼酸盐蓄积预测
Crit Care Med. 2017 Sep;45(9):e941-e946. doi: 10.1097/CCM.0000000000002501.
7
Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.持续静脉-静脉血液滤过中置换液和抗凝剂的选择
Clin Nephrol. 2006 Jan;65(1):34-42. doi: 10.5414/cnp65034.
8
Is Regional Citrate Anticoagulation the Future of Hemodialysis?局部枸橼酸抗凝会是血液透析的未来吗?
Ther Apher Dial. 2016 Jun;20(3):234-9. doi: 10.1111/1744-9987.12429.
9
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.4%枸橼酸钠与肝素作为危重症患者非隧道式血液透析导管封管液的比较:一项多中心随机临床试验
Ann Intensive Care. 2019 Jul 1;9(1):75. doi: 10.1186/s13613-019-0553-4.
10
Trisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolism.三钠柠檬酸诱导血液透析导管中的蛋白质沉淀可能会引起肺栓塞。
Nephrol Dial Transplant. 2012 Jul;27(7):2953-7. doi: 10.1093/ndt/gfs048. Epub 2012 Mar 30.

引用本文的文献

1
Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring.连续性肾脏替代治疗中枸橼酸盐抗凝的安全性:钙监测动态方案的单中心经验
J Clin Med. 2023 Aug 10;12(16):5201. doi: 10.3390/jcm12165201.
2
Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus.连续肾脏替代治疗中局部枸橼酸抗凝管理:中国急诊医师共识的指南推荐。
Mil Med Res. 2023 May 29;10(1):23. doi: 10.1186/s40779-023-00457-9.
3
Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients.

本文引用的文献

1
Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: All Citrates Are Not Created Equal!
Blood Purif. 2016;42(3):219-20. doi: 10.1159/000448801. Epub 2016 Aug 17.
2
Citrate Formulation Determines Filter Lifespan during Continuous Veno-Venous Hemofiltration: A Prospective Cohort Study.枸橼酸盐配方决定持续静脉-静脉血液滤过期间的滤器使用寿命:一项前瞻性队列研究。
Blood Purif. 2015;40(3):194-202. doi: 10.1159/000438820. Epub 2015 Aug 22.
3
Facing acid-base disorders in the third millennium - the Stewart approach revisited.面对第三个千年的酸碱紊乱——再探斯图尔特方法
在 ICU 患者中,使用柠檬酸盐抗凝的连续静脉-静脉血液滤过(CVVH)时,尽管血浆离子钙浓度正常,但仍出现负钙平衡。
J Nephrol. 2023 May;36(4):1019-1026. doi: 10.1007/s40620-022-01482-y. Epub 2022 Nov 7.
4
Regional Hypertonic Citrate Anticoagulation in Membrane Therapeutic Plasma Exchange: A Case Series.膜式治疗性血浆置换中的局部高渗枸橼酸盐抗凝:病例系列
Can J Kidney Health Dis. 2021 Nov 7;8:20543581211054736. doi: 10.1177/20543581211054736. eCollection 2021.
5
A Double Catheter Approach for Extracorporeal CO Removal Integrated Within a Continuous Renal Replacement Circuit.一种集成于连续性肾脏替代回路中的用于体外二氧化碳清除的双导管方法。
J Transl Int Med. 2018 Dec 31;6(4):157-158. doi: 10.2478/jtim-2018-0030. eCollection 2018 Dec.
Int J Nephrol Renovasc Dis. 2014 Jun 4;7:209-17. doi: 10.2147/IJNRD.S62126. eCollection 2014.
4
Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.从实验室到临床的综述:用于连续性肾脏替代治疗的枸橼酸盐,从科学到实践
Crit Care. 2012 Dec 7;16(6):249. doi: 10.1186/cc11645.
5
Citrate anticoagulation for continuous renal replacement therapy in the critically ill.枸橼酸抗凝在危重症连续性肾脏替代治疗中的应用。
Blood Purif. 2010;29(2):191-6. doi: 10.1159/000245646. Epub 2010 Jan 8.
6
Citrate anticoagulation for continuous venovenous hemofiltration.用于连续性静脉-静脉血液滤过的枸橼酸盐抗凝法。
Crit Care Med. 2009 Feb;37(2):545-52. doi: 10.1097/CCM.0b013e3181953c5e.
7
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.危重症患者连续性肾脏替代治疗中局部枸橼酸盐与全身肝素抗凝的比较
Kidney Int. 2005 Jun;67(6):2361-7. doi: 10.1111/j.1523-1755.2005.00342.x.
8
Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.使用市售溶液在连续性静脉-静脉血液透析滤过中进行局部枸橼酸盐抗凝
Nephrol Dial Transplant. 2004 Jan;19(1):171-8. doi: 10.1093/ndt/gfg488.
9
Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.枸橼酸盐与肝素用于连续性静脉-静脉血液滤过抗凝的前瞻性随机研究。
Intensive Care Med. 2004 Feb;30(2):260-265. doi: 10.1007/s00134-003-2047-x. Epub 2003 Nov 5.
10
A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration.一种用于连续性静脉-静脉血液透析滤过的新型枸橼酸盐抗凝方案。
Intensive Care Med. 2003 Jul;29(7):1186-9. doi: 10.1007/s00134-003-1801-4. Epub 2003 May 22.